Synthetica Bio, Inc. — Form D/A
Synthetica Bio, Inc. of Anaheim, CA, a company, filed a Form D amendment with the SEC on 2023-07-05. The offering totals $3.0M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-07-05
- Form: D/A
- Accession: 0001981956-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.5M
- Remaining: $500K
- Investors: 13
- Date of first sale: 2023-05-30
- Revenue range: Decline to Disclose
- SEC file number: 021-484503
Issuer
- Name: Synthetica Bio, Inc.
- CIK: 0001981956
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1950 Corporate Way, Anaheim, CA, 92801
- Phone: (760) 470-4862
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Simon Arkell | Director | Columbus, OH |
| Simon Arkell | Executive Officer | Columbus, OH |
| Alexander Dickinson | Director | Anaheim, CA |
| Alexander Dickinson | Executive Officer | Anaheim, CA |
Other filings by this issuer (3)
More